Metric Analysis: AdaptHealth Corp (AHCO)’s Key Ratios in the Limelight

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

In the latest session, AdaptHealth Corp (NASDAQ: AHCO) closed at $9.50 down -1.76% from its previous closing price of $9.67. In other words, the price has decreased by -$1.76 from its previous closing price. On the day, 0.93 million shares were traded. AHCO stock price reached its highest trading level at $10.01 during the session, while it also had its lowest trading level at $9.425.

Ratios:

For a deeper understanding of AdaptHealth Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.78. For the most recent quarter (mrq), Quick Ratio is recorded 1.11 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 1.60 whereas as Long-Term Debt/Eq ratio is at 1.55.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.

On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.

Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 12 ’24 when Flynn James E sold 114,906 shares for $10.70 per share. The transaction valued at 1,229,494 led to the insider holds 11,528,863 shares of the business.

Flynn James E sold 182,607 shares of AHCO for $2,012,557 on Mar 11 ’24. The 10% Owner now owns 11,643,769 shares after completing the transaction at $11.02 per share. On Mar 08 ’24, another insider, Flynn James E, who serves as the 10% Owner of the company, sold 52,487 shares for $10.93 each. As a result, the insider received 573,652 and left with 11,826,376 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHCO now has a Market Capitalization of 1265419008 and an Enterprise Value of 3497919488. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 0.84. Its current Enterprise Value per Revenue stands at 1.077 whereas that against EBITDA is 5.234.

Stock Price History:

Over the past 52 weeks, AHCO has reached a high of $15.37, while it has fallen to a 52-week low of $6.37. The 50-Day Moving Average of the stock is -7.85%, while the 200-Day Moving Average is calculated to be 2.90%.

Shares Statistics:

For the past three months, AHCO has traded an average of 1.20M shares per day and 1469210 over the past ten days. A total of 132.63M shares are outstanding, with a floating share count of 70.63M. Insiders hold about 46.97% of the company’s shares, while institutions hold 59.71% stake in the company. Shares short for AHCO as of 1714435200 were 7992914 with a Short Ratio of 6.67, compared to 1711584000 on 8211692. Therefore, it implies a Short% of Shares Outstanding of 7992914 and a Short% of Float of 7.8200005.

Most Popular

[the_ad id="945"]